These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7726615)

  • 1. Preventative policies in transfusion associated graft versus host disease in the treatment of cancer.
    Webb DK
    Arch Dis Child; 1994 Dec; 71(6):532-3. PubMed ID: 7726615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood.
    Lowenthal RM; Challis DR; Griffiths AE; Chappell RA; Goulder PJ
    Transfusion; 1993 Jun; 33(6):524-9. PubMed ID: 8516797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Castro G; Merkel PA; Giclas HE; Gibula A; Andersen GE; Corash LM; Lin JS; Green J; Knight V; Stassinopoulos A
    Transfusion; 2018 Jun; 58(6):1506-1515. PubMed ID: 29607502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-associated graft-versus-host disease: current concepts and future trends.
    Seghatchian MJ; Ala F
    Transfus Sci; 1995 Jun; 16(2):99-105. PubMed ID: 10155741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?
    Rodriguez JV; Tormey CA
    Transfus Apher Sci; 2022 Apr; 61(2):103402. PubMed ID: 35288056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiation in the prevention of transfusion associated graft-versus-host disease.
    Webb DK
    Arch Dis Child; 1995 Nov; 73(5):388-9. PubMed ID: 8554351
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation.
    Rosen NR; Weidner JG; Boldt HD; Rosen DS
    Transfusion; 1993 Feb; 33(2):125-7. PubMed ID: 8430450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for irradiated blood components: dose and side effects].
    Eiermann TH
    Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning.
    Jaime-Pérez JC; Villarreal-Villarreal CD; Salazar-Riojas R; Méndez-Ramírez N; Vázquez-Garza E; Gómez-Almaguer D
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):526-30. PubMed ID: 25498924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion associated GVHD.
    Sohi I; Jacob S
    Indian J Pediatr; 2005 Jun; 72(6):533-5. PubMed ID: 15985746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-associated graft-versus-host disease: an overview and two case reports.
    Spector D
    Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.
    Takahashi K; Juji T; Miyamoto M; Uchida S; Akaza T; Tadokoro K; Shibata Y; Ino T; Hidano A
    Lancet; 1994 Mar; 343(8899):700-2. PubMed ID: 7907679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.